Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

ClinicalTrials.gov ID: NCT00945815

Public ClinicalTrials.gov record NCT00945815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

S0910, A Phase II Study of Epratuzumab (NSC-716711) in Combination With Cytarabine and Clofarabine for Patients With Relapsed or Refractory Ph- Negative Precursor B-Cell Acute Lymphoblastic Leukemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Monoclonal antibodies, such as epratuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Drugs used in chemotherapy, such as cytarabine and clofarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving epratuzumab together with cytarabine and clofarabine may kill more cancer cells. PURPOSE: This phase II trial is studying the side effects and how well giving epratuzumab together with cytarabine and clofarabine works in treating patients with relapsed or refractory acute lymphoblastic leukemia.

Study identification

NCT ID
NCT00945815
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
35 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug · Other

Eligibility (public fields only)

Age range
16 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Mar 2013 (Actual)
Completion
Aug 2017 (Actual)
Last update posted
Nov 6, 2017

2010 – 2017

United States locations

U.S. sites
81
U.S. states
19
U.S. cities
60
Facility City State ZIP Site status
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
City of Hope Comprehensive Cancer Center Duarte California 91010-3000 —
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90089-9181 —
University of California Davis Cancer Center Sacramento California 95817 —
Stanford Cancer Center Stanford California 94305-5824 —
University of Colorado Cancer Center at UC Health Sciences Center Aurora Colorado 80045 —
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center Grand Junction Colorado 81502 —
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa Florida 33612-9497 —
Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood Illinois 60153 —
St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove Indiana 46107 —
Reid Hospital & Health Care Services Richmond Indiana 47374 —
Tulane Cancer Center Office of Clinical Research Alexandria Louisiana 71315-3198 —
Hematology-Oncology Clinic Baton Rouge Louisiana 70809 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0942 —
University of Mississippi Cancer Clinic Jackson Mississippi 39216 —
Saint Louis University Cancer Center St Louis Missouri 63110 —
CCOP - Montana Cancer Consortium Billings Montana 59101 —
St. Vincent Healthcare Cancer Care Services Billings Montana 59101 —
Hematology-Oncology Centers of the Northern Rockies - Billings Billings Montana 59102 —
Billings Clinic - Downtown Billings Montana 59107-7000 —
Bozeman Deaconess Cancer Center Bozeman Montana 59715 —
Great Falls Clinic - Main Facility Great Falls Montana 59405 —
Sletten Cancer Institute at Benefis Healthcare Great Falls Montana 59405 —
St. Peter's Hospital Helena Montana 59601 —
Glacier Oncology, PLLC Kalispell Montana 59901 —
Kalispell Regional Medical Center Kalispell Montana 59901 —
Montana Cancer Specialists at Montana Cancer Center Missoula Montana 59807-7877 —
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula Montana 59807 —
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York 14642 —
Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina 28233-3549 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Grandview Hospital Dayton Ohio 45405 —
Good Samaritan Hospital Dayton Ohio 45406 —
David L. Rike Cancer Center at Miami Valley Hospital Dayton Ohio 45409 —
Samaritan North Cancer Care Center Dayton Ohio 45415 —
CCOP - Dayton Dayton Ohio 45420 —
Blanchard Valley Medical Associates Findlay Ohio 45840 —
Middletown Regional Hospital Franklin Ohio 45005-1066 —
Wayne Hospital Greenville Ohio 45331 —
Charles F. Kettering Memorial Hospital Kettering Ohio 45429 —
UVMC Cancer Care Center at Upper Valley Medical Center Troy Ohio 45373-1300 —
Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia Ohio 45385 —
Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina 29425 —
Cancer Centers of the Carolinas - Faris Road Greenville South Carolina 29605 —
Cancer Centers of the Carolinas - Grove Commons Greenville South Carolina 29605 —
CCOP - Greenville Greenville South Carolina 29615 —
Cancer Centers of the Carolinas - Greer Medical Oncology Greer South Carolina 29650 —
Cancer Centers of the Carolinas - Seneca Seneca South Carolina 29672 —
Cancer Centers of the Carolinas - Spartanburg Spartanburg South Carolina 29307 —
Baylor University Medical Center - Houston Houston Texas 77030 —
Ben Taub General Hospital Houston Texas 77030 —
St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital Houston Texas 77030 —
Veterans Affairs Medical Center - Houston Houston Texas 77030 —
American Fork Hospital American Fork Utah 84003 —
Sandra L. Maxwell Cancer Center Cedar City Utah 84720 —
Logan Regional Hospital Logan Utah 84321 —
Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray Utah 84157 —
Val and Ann Browning Cancer Center at McKay-Dee Hospital Center Ogden Utah 84403 —
Utah Valley Regional Medical Center - Provo Provo Utah 84604 —
LDS Hospital Salt Lake City Utah 84143 —
Dixie Regional Medical Center - East Campus St. George Utah 84770 —
Island Hospital Cancer Care Center at Island Hospital Anacortes Washington 98221 —
St. Joseph Cancer Center Bellingham Washington 98225 —
Olympic Hematology and Oncology Bremerton Washington 98310 —
Highline Medical Center Cancer Center Burien Washington 98166 —
Swedish Medical Center - Issaquah Campus Issaquah Washington 98029 —
Columbia Basin Hematology Kennewick Washington 99336 —
Skagit Valley Hospital Cancer Care Center Mount Vernon Washington 98274 —
Harrison Poulsbo Hematology and Onocology Poulsbo Washington 98370 —
Harborview Medical Center Seattle Washington 98104 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109 —
Group Health Central Hospital Seattle Washington 98112 —
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98122-4307 —
Polyclinic First Hill Seattle Washington 98122 —
University Cancer Center at University of Washington Medical Center Seattle Washington 98195 —
North Puget Oncology at United General Hospital Sedro-Woolley Washington 98284 —
Cancer Care Northwest - Spokane South Spokane Washington 99202 —
Evergreen Hematology and Oncology, PS Spokane Washington 99218 —
Wenatchee Valley Medical Center Wenatchee Washington 98801-2028 —
Welch Cancer Center at Sheridan Memorial Hospital Sheridan Wyoming 82801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00945815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00945815 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →